Exact Mass: 232.1675

Exact Mass Matches: 232.1675

Found 85 metabolites which its exact mass value is equals to given mass value 232.1675, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

UNII:513S964LJO

UNII:513S964LJO

C14H20N2O (232.1576)


   

Albine

1,5-Methano-10H-pyrido[1,2-a][1,5]diazocin-10-one,1,2,3,4,5,6,11,11a-octahydro-2-(2-propen-1-yl)-, (1S,2R,5R,11aR)-

C14H20N2O (232.1576)


   

2,6-Pipecoloxylidide

N-(2,6-dimethylphenyl)piperidine-2-carboximidic acid

C14H20N2O (232.1576)


2,6-Pipecoloxylidide is a metabolite of bupivacaine. Bupivacaine is a local anaesthetic drug belonging to the amino amide group. It is commonly marketed under various trade names, including Marcain, Marcaine (CareStream Dental), Sensorcaine (Astra Zeneca) and Vivacaine (Septodont). (Wikipedia)

   

norfentanyl

N-Phenyl-N-(piperidin-4-yl)propionamide

C14H20N2O (232.1576)


norfentanyl is a metabolite of fentanyl. Fentanyl (also known as fentanil, brand names Sublimaze, Actiq, Durogesic, Duragesic, Fentora, Matrifen, Haldid, Onsolis, Instanyl, Abstral, Lazanda and others) is a potent, synthetic narcotic analgesic with a rapid onset and short duration of action. It is a strong agonist at the μ-opioid receptors. Historically it has been used to treat breakthrough pain and is commonly used in pre-procedures as a pain reliever as well as an anesthetic in combination with a benzodiazepine. (Wikipedia)

   

Tymazoline

2-[5-methyl-2-(propan-2-yl)phenoxymethyl]-4,5-dihydro-1H-imidazole

C14H20N2O (232.1576)


Tymazoline is only found in individuals that have used or taken this drug. It is a nasal preparation.Thymazen causes vasoconstriction of the nasal mucosa, reducing congestion and thus the swelling of the mucosa. Also reduces the secretions from the nose. Thymazen acts on alpha-adrenergic receptors, which reduces local inflammation of the nasal mucosa especially if their cause is an allergy. R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AA - Sympathomimetics, plain C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist

   

5-Methoxy-N-isopropyltryptamine

[2-(5-methoxy-1H-indol-3-yl)ethyl](propan-2-yl)amine

C14H20N2O (232.1576)


   
   

3-(2-(Diethylamino)ethyl)-1H-indol-4-ol

3-(2-(Diethylamino)ethyl)-1H-indol-4-ol

C14H20N2O (232.1576)


   
   

6-hydroxydiethyltryptamine

6-hydroxydiethyltryptamine

C14H20N2O (232.1576)


   

3,11-dihydroxydodecanoic Acid

3,11-dihydroxydodecanoic Acid

C12H24O4 (232.1675)


   

SCHEMBL4804235

SCHEMBL4804235

C12H24O4 (232.1675)


   

Urea, N-isopropyl-N-(7-thiaoctyl)-

Urea, N-isopropyl-N-(7-thiaoctyl)-

C11H24N2OS (232.1609)


   

(1R)-4c-Allyl-(11ac)-1,4,5,6,9,10,11,11a-octahydro-1r,5c-methano-pyrido[1,2-a][1,5]diazocin-8-on|(1R)-4c-allyl-(11ac)-1,4,5,6,9,10,11,11a-octahydro-1r,5c-methano-pyrido[1,2-a][1,5]diazocin-8-one

(1R)-4c-Allyl-(11ac)-1,4,5,6,9,10,11,11a-octahydro-1r,5c-methano-pyrido[1,2-a][1,5]diazocin-8-on|(1R)-4c-allyl-(11ac)-1,4,5,6,9,10,11,11a-octahydro-1r,5c-methano-pyrido[1,2-a][1,5]diazocin-8-one

C14H20N2O (232.1576)


   

(10R,11R)-dihydroxydodecanoic acid|10(R),11(R)-dihydroxydodecanoic acid

(10R,11R)-dihydroxydodecanoic acid|10(R),11(R)-dihydroxydodecanoic acid

C12H24O4 (232.1675)


   

(-)-(3S,6R)-3,6-dihydroxy-10-methylundecanoic acid|(3S,6R)-3,6-dihydroxy-10-methylundecanoic acid

(-)-(3S,6R)-3,6-dihydroxy-10-methylundecanoic acid|(3S,6R)-3,6-dihydroxy-10-methylundecanoic acid

C12H24O4 (232.1675)


   

Norfentanyl

N-Phenyl-N-(4-piperidinyl)propanamide

C14H20N2O (232.1576)


A monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of 4-(N-phenyl)piperidin-4-amine with propanoic acid. A major metabolite of fentanyl. CONFIDENCE standard compound; EAWAG_UCHEM_ID 3612 EAWAG_UCHEM_ID 3612; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 1552

   

LID_233.1648_14.5

LID_233.1648_14.5

C14H20N2O (232.1576)


CONFIDENCE Probable structure via diagnostic evidence, tentative identification (Level 2b); INTERNAL_ID 804

   

2-Piperidinecarboxamide(PPX)

N-(2,6-Dimethylphenl)-2-Piperidine Carboxamide

C14H20N2O (232.1576)


   

Pernazene

2-[5-methyl-2-(propan-2-yl)phenoxymethyl]-4,5-dihydro-1H-imidazole

C14H20N2O (232.1576)


R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AA - Sympathomimetics, plain C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist

   

2-(2,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(2,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C14H21BO2 (232.1635)


   

8a-(4-methoxyphenyl)-2,3,4,6,7,8-hexahydro-1H-pyrrolo[1,2-a]pyrimidine

8a-(4-methoxyphenyl)-2,3,4,6,7,8-hexahydro-1H-pyrrolo[1,2-a]pyrimidine

C14H20N2O (232.1576)


   

1,3,2-Dioxaborinane,5-methyl-2-(4-methylphenyl)-5-propyl-

1,3,2-Dioxaborinane,5-methyl-2-(4-methylphenyl)-5-propyl-

C14H21BO2 (232.1635)


   

2-(3,5-Dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(3,5-Dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C14H21BO2 (232.1635)


   

4-CHLOROPHENYLACETYLCHLORIDE

4-CHLOROPHENYLACETYLCHLORIDE

C14H20N2O (232.1576)


   

4-[(4-methylperhydro-1,4-diazepin-1-yl)methyl]benzaldehyde

4-[(4-methylperhydro-1,4-diazepin-1-yl)methyl]benzaldehyde

C14H20N2O (232.1576)


   

(5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL)BORONIC ACID

(5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL)BORONIC ACID

C14H21BO2 (232.1635)


   

N-methyl-N-(4-phenylpiperidin-4-yl)acetamide

N-methyl-N-(4-phenylpiperidin-4-yl)acetamide

C14H20N2O (232.1576)


   

4-Hydroxy-N,N-diethyltryptamine

4-Hydroxy-N,N-diethyltryptamine

C14H20N2O (232.1576)


   

tridecanoyl chloride

tridecanoyl chloride

C13H25ClO (232.1594)


   

1-[4-(4-Ethyl-1-piperazinyl)phenyl]ethanone

1-[4-(4-Ethyl-1-piperazinyl)phenyl]ethanone

C14H20N2O (232.1576)


   

2H-Pyran,3-(diethoxymethyl)-2-ethoxytetrahydro-

2H-Pyran,3-(diethoxymethyl)-2-ethoxytetrahydro-

C12H24O4 (232.1675)


   

N-[3-(Diethoxymethylsilyl)propyl]ethylenediamine

N-[3-(Diethoxymethylsilyl)propyl]ethylenediamine

C10H24N2O2Si (232.1607)


   

(S)-2-amino-3-phenyl-1-(piperidin-1-yl)propan-1-one

(S)-2-amino-3-phenyl-1-(piperidin-1-yl)propan-1-one

C14H20N2O (232.1576)


   

2-(2,3-Dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(2,3-Dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C14H21BO2 (232.1635)


   

2-(3,4-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(3,4-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C14H21BO2 (232.1635)


   

4-Acetamido-1-benzylpiperidine

4-Acetamido-1-benzylpiperidine

C14H20N2O (232.1576)


   

Pyrrocaine

Pyrrocaine

C14H20N2O (232.1576)


C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

4-(trans-4-Ethylcyclohexyl)phenylboronic acid

4-(trans-4-Ethylcyclohexyl)phenylboronic acid

C14H21BO2 (232.1635)


   

3-Aminomethyl-3-fluoropiperidine-1-carboxylic acid tert-butyl ester

3-Aminomethyl-3-fluoropiperidine-1-carboxylic acid tert-butyl ester

C11H21FN2O2 (232.1587)


   
   

TERT-BUTYL-4-AMINOMETHYL-4-FLUOROPIPERIDINE-1-CARBOXYLATE

TERT-BUTYL-4-AMINOMETHYL-4-FLUOROPIPERIDINE-1-CARBOXYLATE

C11H21FN2O2 (232.1587)


   

2-Phenylethyl-1-boronic acid pinacol ester

2-Phenylethyl-1-boronic acid pinacol ester

C14H21BO2 (232.1635)


   

3-AMINO-N-CYCLOHEXYL-N-METHYL-BENZAMIDE

3-AMINO-N-CYCLOHEXYL-N-METHYL-BENZAMIDE

C14H20N2O (232.1576)


   

4,4,5,5-Tetramethyl-2-(1-phenylethyl)-1,3,2-dioxaborolane

4,4,5,5-Tetramethyl-2-(1-phenylethyl)-1,3,2-dioxaborolane

C14H21BO2 (232.1635)


   

4-Ethylphenylboronic acid pinacol ester

4-Ethylphenylboronic acid pinacol ester

C14H21BO2 (232.1635)


   

N-(4-METHYLBENZYL)PIPERIDINE-4-CARBOXAMIDE

N-(4-METHYLBENZYL)PIPERIDINE-4-CARBOXAMIDE

C14H20N2O (232.1576)


   

1-(4-((4-METHYLPIPERAZIN-1-YL)METHYL)PHENYL)ETHANONE

1-(4-((4-METHYLPIPERAZIN-1-YL)METHYL)PHENYL)ETHANONE

C14H20N2O (232.1576)


   

N-benzyl-4-methylpiperidine-4-carboxamide

N-benzyl-4-methylpiperidine-4-carboxamide

C14H20N2O (232.1576)


   

tert-butyl N-[(4-fluoropiperidin-4-yl)methyl]carbamate

tert-butyl N-[(4-fluoropiperidin-4-yl)methyl]carbamate

C11H21FN2O2 (232.1587)


   

1-(4-(benzylamino)piperidin-1-yl)ethanone

1-(4-(benzylamino)piperidin-1-yl)ethanone

C14H20N2O (232.1576)


   

1-Benzyl-4-glycidylpiperazine

1-Benzyl-4-glycidylpiperazine

C14H20N2O (232.1576)


   

2,4,6-Trimethylbenzeneboronic acid neopentyl glycol cyclic ester

2,4,6-Trimethylbenzeneboronic acid neopentyl glycol cyclic ester

C14H21BO2 (232.1635)


   

1-{3-[Dimethoxy(methyl)silyl]propyl}piperazine

1-{3-[Dimethoxy(methyl)silyl]propyl}piperazine

C10H24N2O2Si (232.1607)


   

4,4,5,5-TETRAMETHYL-2-(4-METHYLBENZYL)-1,3,2-DIOXABOROLANE

4,4,5,5-TETRAMETHYL-2-(4-METHYLBENZYL)-1,3,2-DIOXABOROLANE

C14H21BO2 (232.1635)


   

1-(2-CYCLOPENTENYL)-2-PROPANONE

1-(2-CYCLOPENTENYL)-2-PROPANONE

C13H20N4 (232.1688)


   

2-(5-methoxy-2-methyl-1H-indol-3-yl)-N,N-dimethylethanamine

2-(5-methoxy-2-methyl-1H-indol-3-yl)-N,N-dimethylethanamine

C14H20N2O (232.1576)


   

1,2-BIS(TERT-BUTYLTHIO)ETHANE:DIBORANE COMPLEX

1,2-BIS(TERT-BUTYLTHIO)ETHANE:DIBORANE COMPLEX

C10H26B2S2 (232.1662)


   

(S)-N-tert-Butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide

(S)-N-tert-Butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide

C14H20N2O (232.1576)


   

2,3-Dihydroxydodecanoic acid

2,3-Dihydroxydodecanoic acid

C12H24O4 (232.1675)


   

2,3-Dihydroxypropyl nonan-1-oate

2,3-Dihydroxypropyl nonan-1-oate

C12H24O4 (232.1675)


   

3-{3-[(Dimethylamino)methyl]-1h-Indol-7-Yl}propan-1-Ol

3-{3-[(Dimethylamino)methyl]-1h-Indol-7-Yl}propan-1-Ol

C14H20N2O (232.1576)


   

TYMAZOLINE

TYMAZOLINE

C14H20N2O (232.1576)


R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AA - Sympathomimetics, plain C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist

   

N-(2,6-dimethylphenyl)-N2-ethenyl-N2-ethylglycinamide

N-(2,6-dimethylphenyl)-N2-ethenyl-N2-ethylglycinamide

C14H20N2O (232.1576)


   

(S)-N-(2,6-Dimethylphenyl)-2-piperidinecarboxamide

(S)-N-(2,6-Dimethylphenyl)-2-piperidinecarboxamide

C14H20N2O (232.1576)


   

Hypusinate

Hypusinate

C10H22N3O3- (232.1661)


A L-alpha-amino acid anion obtained by the deprotonation of the carboxy group of hypusine.

   

3,12-Dihydroxylauric acid

3,12-Dihydroxylauric acid

C12H24O4 (232.1675)


A dihydroxy monocarboxylic acid that consists of lauric (dodecanoic) acid bearing two hydroxy substituents at positions 3 and 12.

   

gamma-aminobutanoyl-L-lysine

gamma-aminobutanoyl-L-lysine

C10H22N3O3+ (232.1661)


   

(3R)-3,12-dihydroxylauric acid

(3R)-3,12-dihydroxylauric acid

C12H24O4 (232.1675)


A dihydroxy monocarboxylic acid that is 12-hydroxylauric acid in which the pro-R hydrogen beta to the carboxy group is replaced by a hydroxy group.

   

(3R,11R)-3,11-dihydroxylauric acid

(3R,11R)-3,11-dihydroxylauric acid

C12H24O4 (232.1675)


An (omega-1)-hydroxy fatty acid that is (11R)-11-hydroxylauric acid in which the 3-pro-R hydrogen is replaced by a hydroxy group.

   

gamma-L-glutamylcadaverine

gamma-L-glutamylcadaverine

C10H22N3O3+ (232.1661)


   

(2R)-2-hydroperoxydodecanoic acid

(2R)-2-hydroperoxydodecanoic acid

C12H24O4 (232.1675)


   

Hexyl (3S)-3-hydroxy-5-methoxypentanoate

Hexyl (3S)-3-hydroxy-5-methoxypentanoate

C12H24O4 (232.1675)


   

8-Methoxy-4a,9a-dimethyl-2,3,4,4a,9,9a-hexahydro-1H-pyrido[2,3-b]indole

8-Methoxy-4a,9a-dimethyl-2,3,4,4a,9,9a-hexahydro-1H-pyrido[2,3-b]indole

C14H20N2O (232.1576)


   
   

N-(2,6-dimethylphenyl)piperidine-2-carboxamide

N-(2,6-dimethylphenyl)piperidine-2-carboxamide

C14H20N2O (232.1576)


   

(S)-2,6-Pipecoloxylidide

(S)-N-(2,6-Dimethylphenyl)-2-piperidinecarboxamide

C14H20N2O (232.1576)


   

3,6-dihydroxy-10-methylundecanoic acid

3,6-dihydroxy-10-methylundecanoic acid

C12H24O4 (232.1675)


   

12-(prop-2-en-1-yl)-7,11-diazatricyclo[7.3.1.0²,⁷]tridec-5-en-4-one

12-(prop-2-en-1-yl)-7,11-diazatricyclo[7.3.1.0²,⁷]tridec-5-en-4-one

C14H20N2O (232.1576)


   

(1s,2r,9r,12r)-12-(prop-2-en-1-yl)-7,11-diazatricyclo[7.3.1.0²,⁷]tridec-5-en-4-one

(1s,2r,9r,12r)-12-(prop-2-en-1-yl)-7,11-diazatricyclo[7.3.1.0²,⁷]tridec-5-en-4-one

C14H20N2O (232.1576)


   

(3s,6r)-3,6-dihydroxy-10-methylundecanoic acid

(3s,6r)-3,6-dihydroxy-10-methylundecanoic acid

C12H24O4 (232.1675)


   

(1r,2r,9r,12r)-12-(prop-2-en-1-yl)-7,11-diazatricyclo[7.3.1.0²,⁷]tridec-5-en-4-one

(1r,2r,9r,12r)-12-(prop-2-en-1-yl)-7,11-diazatricyclo[7.3.1.0²,⁷]tridec-5-en-4-one

C14H20N2O (232.1576)


   

(1r,9s,10s)-10-(prop-2-en-1-yl)-7,11-diazatricyclo[7.3.1.0²,⁷]tridec-2-en-4-one

(1r,9s,10s)-10-(prop-2-en-1-yl)-7,11-diazatricyclo[7.3.1.0²,⁷]tridec-2-en-4-one

C14H20N2O (232.1576)


   

(1r,2r,9s,12r)-12-(prop-2-en-1-yl)-7,11-diazatricyclo[7.3.1.0²,⁷]tridec-5-en-4-one

(1r,2r,9s,12r)-12-(prop-2-en-1-yl)-7,11-diazatricyclo[7.3.1.0²,⁷]tridec-5-en-4-one

C14H20N2O (232.1576)


   

(1r,2r,9r,12s)-12-(prop-2-en-1-yl)-7,11-diazatricyclo[7.3.1.0²,⁷]tridec-5-en-4-one

(1r,2r,9r,12s)-12-(prop-2-en-1-yl)-7,11-diazatricyclo[7.3.1.0²,⁷]tridec-5-en-4-one

C14H20N2O (232.1576)